Spring Bank Pharmaceuticals

About:

Spring Bank Pharmaceuticals is a discovery company developing a new class of pharmaceuticals called small molecule nucleic acid hybrids.

Website: http://www.springbankpharm.com

Twitter/X: springbankpharm

Top Investors: National Institutes of Health

Description:

Spring Bank Pharmaceuticals is an IND-stage drug discovery company. Based on its proprietary platform technology, the company is developing a pipeline of products representing a new class of pharmaceuticals they call small molecule nucleic acid hybrids with a wide range of applications and multi-billion dollar market potential.

Total Funding Amount:

$26M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Milford, Massachusetts, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)springbankpharm.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2015-01-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai